Gout
📧 Sign up to get email alerts when something new happens for Gout.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-01-07Clinical Trial Update: A Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Oral F-02-2-Na Tablets in Adult Subjects [Phase 1]
A Phase 1 study is evaluating the safety, tolerability, and pharmacokinetics of oral F-02-2-Na tablets in adults with hyperuricemia with or …
-
CLINICAL_TRIALS research · 2025-12-31Clinical Trial Update: An Exploratory Clinical Study on the Protective Effect of Cycling on the Ankle Joint in Gout [NA]
This is an exploratory clinical study investigating whether cycling has a protective effect on the ankle joint in patients with gout; the st…
-
CLINICAL_TRIALS trial_result · 2025-12-22Clinical Trial Update: Phase 2b/3 Study to Assess ABP-671 a Novel URAT1 Inhibitor in Participants With Gout [Phase 2, Phase 3]
Phase 2b/3 trial evaluating ABP-671, a URAT1 inhibitor, for gout has completed according to the update.
-
CLINICAL_TRIALS research · 2025-12-15Clinical Trial Update: Effect of Dotinurad in Hyperuricemia With Hypertension [Phase 4]
A Phase 4 clinical trial evaluating dotinurad for hyperuricemia (with gout) and hypertension is currently recruiting.
-
CLINICAL_TRIALS research · 2025-12-08Clinical Trial Update: Safety and Efficacy of ABP-745 in Participants With an Acute Gout Flare [Phase 2]
A Phase 2 trial is evaluating the safety and efficacy of ABP-745 in participants with an acute gout flare. The study is currently recruiting…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-12-03Clinical Trial Update: A Study to Assess Efficay and Safety of LC350189 Different Doses in Gout Patients With Hyperuricemia [Phase 2]
A Phase 2 trial evaluated different doses of LC350189 for efficacy and safety in patients with gout and hyperuricemia; trial results have be…
-
CLINICAL_TRIALS trial_result · 2025-12-03Clinical Trial Update: A Study of SEL-212 in Patients With Gout Refractory to Conventional Therapy II [Phase 3]
A Phase 3 study of SEL-212 in patients with chronic gout refractory to conventional therapy has completed and posted results.
-
CLINICAL_TRIALS trial_result · 2025-12-03Clinical Trial Update: Gout in the ED and Improving Research Participation [NA]
This clinical trial update reports on a gout study conducted in the emergency department, including efforts to improve participation in rese…
-
CLINICAL_TRIALS research · 2025-11-24Clinical Trial Update: UR+AIMS Gout Wearable Skin Uric Acid Monitor Study [NA]
The UR+AIMS Gout Wearable Skin Uric Acid Monitor study conducted by the University of California, Los Angeles, evaluating a wearable device …
-
CLINICAL_TRIALS trial_result · 2025-11-12Clinical Trial Update: Rural Hospital-Level Care at Home for Acutely Ill Adults [NA]
This clinical trials.gov entry notes that the Brigham and Women's Hospital study on rural hospital-level care at home for acutely ill adults…
-
CLINICAL_TRIALS trial_result · 2025-10-29Clinical Trial Update: Tigulixostat, Phase 3 Study, Placebo Controlled in Gout Patients [Phase 3]
LG Chem reports completion of a Phase 3, placebo-controlled trial of tigulixostat in patients with gout and hyperuricemia; the study status …
-
FDA label_change · 2025-10-16FDA Approved: ALLOPURINOL — Supplemental Application (Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.)
FDA granted a supplemental approval for ALLOPURINOL submitted by Heritage Pharmaceuticals d/b/a Avet Pharmaceuticals Inc. to update the prod…
-
EMA approval · 2025-10-13EMA Authorised: Ilaris (Canakinumab) — Novartis Europharm Limited
The EMA authorised Ilaris (canakinumab) for use in Cryopyrin-Associated Periodic Syndromes, juvenile idiopathic arthritis, and gout.
-
FDA approval · 2025-10-03FDA Approved: NAPROXEN — Original Application (Aurobindo Pharma Limited)
FDA approved Naproxen from Aurobindo Pharma Limited as an original generic application (ANDA 216504). Naproxen is a nonsteroidal anti-inflam…
-
CLINICAL_TRIALS trial_result · 2025-10-02Clinical Trial Update: Clinical Study of HR091506 Tablets in Treatment of Gout With Hyperuricemia in Adults [Phase 3]
A Phase 3 clinical trial evaluating HR091506 tablets for gout with hyperuricemia in adults has completed.
-
CLINICAL_TRIALS trial_result · 2025-10-01Clinical Trial Update: A Phase 4, Open-label Study of KRYSTEXXA® (Pegloticase) Co-administered With Methotrexate (MTX) in Patients With Uncontrolled Gout (FORWARD OL) [Phase 4]
Phase 4 open-label trial evaluating co-administration of KRYSTEXXA (pegloticase) with methotrexate in patients with uncontrolled gout; study…
-
CLINICAL_TRIALS research · 2025-09-30Clinical Trial Update: Prevalence of Musculoskeletal Complaints in Nursing Home Residents
This clinical trial update reports on the prevalence of musculoskeletal complaints among nursing home residents. It highlights conditions su…
-
CLINICAL_TRIALS research · 2025-09-25Clinical Trial Update: Treat-to-Target Serum Urate Versus Treat-to-Avoid Symptoms in Gout [Phase 4]
This clinical trial update notes a Phase 4 study comparing treat-to-target serum urate with treat-to-avoid symptoms in gout, currently recru…
-
CLINICAL_TRIALS research · 2025-09-18Clinical Trial Update: Nurse-Led Telehealth for Gout [NA]
A clinical trial update indicates a nurse-led telehealth approach is being studied to support gout management, including health literacy and…
-
CLINICAL_TRIALS trial_result · 2025-09-17Clinical Trial Update: Phase 3 Evaluation of Efficacy and Safety of AR882 in Gout Patients (AR882-301) [Phase 3]
This entry notes a Phase 3 clinical trial (AR882-301) evaluating the efficacy and safety of AR882 in gout patients. The trial is currently a…
-
CLINICAL_TRIALS trial_result · 2025-09-12Clinical Trial Update: Vegetarian Diet and Chronic Degenerative Diseases
Completed clinical trial evaluating the impact of a vegetarian diet on dementia, depression, and other chronic diseases.
-
CLINICAL_TRIALS research · 2025-09-12Clinical Trial Update: Evolution of Tophus and Erosions of Hands and Feet at DECT [NA]
Clinical trial update for a DECT imaging study of tophaceous gout affecting the hands and feet; the study is currently active but not recrui…
-
CLINICAL_TRIALS trial_result · 2025-09-11Clinical Trial Update: A Study of SEL-212 in Patients With Gout Refractory to Conventional Therapy [Phase 3]
A Phase 3 trial evaluating SEL-212 in patients with gout refractory to conventional therapy has completed. Results were posted on 2025-09-11…
-
CLINICAL_TRIALS research · 2025-09-10Clinical Trial Update: Imagery as Biomarker of Gout [NA]
This clinical trial update describes evaluating imagery as a biomarker for gout in patients with hyperuricemia; the study is currently activ…
-
CLINICAL_TRIALS trial_result · 2025-08-17Clinical Trial Update: A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Oral ABP-745 Administration in Healthy Volunteers [Phase 1]
Phase 1 study evaluating safety, tolerability, and pharmacokinetics of oral ABP-745 in healthy volunteers has completed.